<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新康界 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-21T11:23:27+08:00</updated>
  <subtitle>中康资讯旗下品牌，中国领先的医药健康产业财经新媒体。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>创新药企业加速布局CDK4/6靶点抑制剂</title>
    <updated>2020-11-20T16:39:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/JuWm-1JSNOSTH9YeJ7cIpw</id>
    <link href="https://mp.weixin.qq.com/s/JuWm-1JSNOSTH9YeJ7cIpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药今日上市！三年估值翻了十四倍！！暗盘涨6.53%！！！</title>
    <updated>2020-11-19T23:44:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/vS8AUF90B_gVh_hjtb4Mbw</id>
    <link href="https://mp.weixin.qq.com/s/vS8AUF90B_gVh_hjtb4Mbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：贝达药业1类创新药恩莎替尼获批上市，合源生物新一轮融资4.5亿元用于CAR-T产品开发</title>
    <updated>2020-11-19T23:44:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/6rw4nc8o6EkuHAYqNHgptw</id>
    <link href="https://mp.weixin.qq.com/s/6rw4nc8o6EkuHAYqNHgptw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百花齐放的PD-(L)1联合疗法，红海中的一片蓝海</title>
    <updated>2020-11-19T19:33:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/E05ek7VJlezWVQU528MI1w</id>
    <link href="https://mp.weixin.qq.com/s/E05ek7VJlezWVQU528MI1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>健之佳明日申购！零售药店的“后浪”来袭</title>
    <updated>2020-11-18T17:34:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/cuEHv0Gf32EEUiqbaetvyw</id>
    <link href="https://mp.weixin.qq.com/s/cuEHv0Gf32EEUiqbaetvyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>狼来了！Amazon Pharmacy正式上线！</title>
    <updated>2020-11-18T17:34:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/bFp3yo4Ew5dJF0zQ_8Ei8g</id>
    <link href="https://mp.weixin.qq.com/s/bFp3yo4Ew5dJF0zQ_8Ei8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：Moderna新冠疫苗三期有效率达94.5%，百济神州计划科创板上市</title>
    <updated>2020-11-18T17:34:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/jc02mnimf5YKgeBqlcuruQ</id>
    <link href="https://mp.weixin.qq.com/s/jc02mnimf5YKgeBqlcuruQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>余文心：一名医药分析师眼中的中国医药产业十年</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/FX2AhIjvbo2ZU4leFE-cug</id>
    <link href="https://mp.weixin.qq.com/s/FX2AhIjvbo2ZU4leFE-cug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大健康产业投资并购动态周报Vol.26</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/tYwyrMXdgENg7IM6CnpE-A</id>
    <link href="https://mp.weixin.qq.com/s/tYwyrMXdgENg7IM6CnpE-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明年医药板块怎么走？磨底+结构性行情</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/XEbKuHpjibAwJbKjbKEe9g</id>
    <link href="https://mp.weixin.qq.com/s/XEbKuHpjibAwJbKjbKEe9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判：中国特色“医保”悬崖！</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/p9FnoNB9DfsbtOt5iwKegw</id>
    <link href="https://mp.weixin.qq.com/s/p9FnoNB9DfsbtOt5iwKegw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首宣！药品监管科学&amp;药物创新研讨会——暨首届《中国食品药品监管》杂志学术年会会议通知</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/HCXt_Ly7578CQ_LPT59TQA</id>
    <link href="https://mp.weixin.qq.com/s/HCXt_Ly7578CQ_LPT59TQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：京东健康通过港交所聆讯，民族药、中药饮片可纳入省级医保范围​</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/1NrB1DJ6UEB-3uM0iaUs0g</id>
    <link href="https://mp.weixin.qq.com/s/1NrB1DJ6UEB-3uM0iaUs0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从进博会和三季报看17家跨国药企在中国市场的创新加码</title>
    <updated>2020-11-14T14:21:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/R-CW53CYGVsAdHPbbEDhTQ</id>
    <link href="https://mp.weixin.qq.com/s/R-CW53CYGVsAdHPbbEDhTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：处方药有望网售，国药新冠灭活疫苗好于预期</title>
    <updated>2020-11-14T14:21:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/p4UWK9WhxO7kd2U7P3NL_A</id>
    <link href="https://mp.weixin.qq.com/s/p4UWK9WhxO7kd2U7P3NL_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“兽爷”，创新药研发不是这么看的</title>
    <updated>2020-11-13T10:42:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/jareA45A0TSz1LyEoZ4JjA</id>
    <link href="https://mp.weixin.qq.com/s/jareA45A0TSz1LyEoZ4JjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>网售处方药开闸在即，重磅征求意见稿来了！</title>
    <updated>2020-11-13T10:42:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/OD8x5FD7vfBZAKwkZ9oCYw</id>
    <link href="https://mp.weixin.qq.com/s/OD8x5FD7vfBZAKwkZ9oCYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞免疫疗法：盛名之下，其实难副？</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/naCRa6hvlCHnHmuzApoBng</id>
    <link href="https://mp.weixin.qq.com/s/naCRa6hvlCHnHmuzApoBng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曾受邀去AZ做分享！余文心的医药十年报告讲了什么？今晚8点揭晓</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Wlg_XN_AjXhcW40Wrmj8dA</id>
    <link href="https://mp.weixin.qq.com/s/Wlg_XN_AjXhcW40Wrmj8dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高瓴等巨头重投2千亿 催生万亿级健康公司</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/PWBgo0L5zaxVqQR6ApKRJA</id>
    <link href="https://mp.weixin.qq.com/s/PWBgo0L5zaxVqQR6ApKRJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>